We’re headed to Prague next week for BioEquity Europe 2026. Our CEO Dr. Christoph Korpus, MBA’s #presentation will highlight our pioneering and differentiated antibody-drug conjugate (ADC) technology platforms, including our cytotoxic antifolate linker-drug platform, ByonBoost™ immune-stimulatory linker-drug platform, and our ByonGuard™ masking technology for conditional activation. We hope to see you at Christoph’s presentation if you are attending #BioEquity, otherwise would love to meet to discuss our platforms and fully-integrated discovery and development capabilities. Reach out to BD@Byondis.com or connect via the partneringONE™ platform to schedule a meeting. #ADCs #BioEquity2026 #MakeHopeReal #Partnering #Innovation #BioEquityEurope
Byondis’ Post
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development